2005
DOI: 10.1590/s0004-27492005000400026
|View full text |Cite
|
Sign up to set email alerts
|

Sarcoma granulocítico em órbita: relato de caso

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
2
0
4

Year Published

2009
2009
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 16 publications
0
2
0
4
Order By: Relevance
“…Most cases, in patients without a previous diagnosis, progress to AML within a few months. However, some patients do not develop leukemic hematologic evidence of the disease for as long as 30 months following the presence of an orbital tumor 21. In our case, the orbital mass preceded any hematologic manifestations at the time of presentation.…”
Section: Discussionmentioning
confidence: 52%
“…Most cases, in patients without a previous diagnosis, progress to AML within a few months. However, some patients do not develop leukemic hematologic evidence of the disease for as long as 30 months following the presence of an orbital tumor 21. In our case, the orbital mass preceded any hematologic manifestations at the time of presentation.…”
Section: Discussionmentioning
confidence: 52%
“…10 In most cases, MS progresses to AML in few months but in a few, they did not develop hematologic malignancy for as long as 30 months. 11 In the absence of systemic leukemic manifestations, the diagnosis of orbital MS can be challenging, and the other differentials are malignant lymphoma, rhabdomyosarcoma, neuroblastoma, retinoblastoma, small round cell tumors, Ewings sarcoma and metastasis. 12 MS is the second commonest orbital tumor after Burkitt's lymphoma that causes proptosis.…”
Section: Case Reportmentioning
confidence: 99%
“…Menos frequentes são a orbita, seios paranasais e sistema nervoso central 3 . Pode anteceder, acompanhar ou indicar recorrência de uma LMA já tratada 4 , e é mais frequente em crianças do que em adultos 5 . Seu surgimento na fase de remissão das leucemias é fator de mau prognóstico, embora tenham sito relatados casos de boa evolução com diagnóstico precoce e tratamento adequado 21 .…”
Section: Introductionunclassified